A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 (Stoss Therapy) in Pediatric Patients Undergoing HSCT to Prevent Vitamin D Deficiency and Insufficiency During Transplant
Sponsor: Phoenix Children's Hospital
Listed as NCT03176849, this PHASE4 trial focuses on Aplastic Anemia and Blood Disorder and remains completed. Sponsored by Phoenix Children's Hospital, it has been updated 7 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Completed PHASE4
Status: Enrolling By Invitation → Completed
-
Jan 2019 — Dec 2020 [monthly]
Enrolling By Invitation PHASE4
Status: Not Yet Recruiting → Enrolling By Invitation
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2019 [monthly]
Not Yet Recruiting PHASE4
-
Jul 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Phoenix Children's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .